Nalaganje...
Therapeutic use and profile of toxicity of the FOLFOX4 regimen
Introduction: Since the publication of the MOSAIC test results in 2004, the FOLFOX4 regimen has been established as an adjuvant treatment which is recommended in stage III colorectal cancer. The aim of this study is to assess the use of this regimen in our field and to describe its toxicity.Methods:...
Shranjeno v:
| izdano v: | Farmacia Hospitalaria |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Sociedad Española de Farmacia Hospitalaria
2009
|
| Teme: | |
| Online dostop: | https://www.redalyc.org/articulo.oa?id=365961789005 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|